At the PMWC conference, Adrian Lee, PhD, Director of the Institute for Precision Medicine (IPM), chaired the Clinical Utility of Liquid Biopsies track, leading a critical discussion on “Improving Sensitivity of MRD and MCED – Tumor-agnostic vs. Tumor-informed ctDNA Approaches.” Joining him on the panel was Marija Balic, MD, ScD, MBA, (UPMC Hillman Cancer Center) co-director of the Magee Women’s Cancer Program and clinical co-leader of the Women’s Cancer Research Center (WCRC). A leader in breast clinical science, she oversees Pitt and UPMC’s breast cancer program.
